The Wall Street Journal – April 26
So far, Moffitt has treated more than 15 insured patients. “The financial realities of this have not been what we expected,” says Yvette Tremonti, Moffitt’s chief financial officer. “We’re not losing money, but we are certainly not making money.”
Tampa Bay Times – April 26
In 1986, when the H. Lee Moffitt Cancer Center opened on the USF campus, administrators quickly hired the married father of two. He became a senior member of Moffitt’s Thoracic Oncology program, president and chief executive Alan List said.
Targeted Oncology – April 25
In an interview with Targeted Oncology, Frederick L. Locke, MD, a medical oncologist at Moffitt Cancer Center, investigator on ZUMA-2, and co-lead investigator on ZUMA-1, discussed the ongoing ZUMA-2 trial investigating axi-cel for patients with MCL.
OncLive – April 25
“Now, we know that many patients may not need chemotherapy, so we’re trying to promote the use of upfront endocrine therapy,” says Khong, a medical oncologist at Moffitt Cancer Center.
The ASCO Post – April 25
Dr. Neelapu and Frederick L. Locke, MD, of H. Lee Moffitt Cancer Center and Research Institute, contributed equally to The New England Journal of Medicine article.
The Laker/Lutz News – April 25
Members of the GFWC Lutz-Land O’ Lakes Woman’s Club hosted and served a brunch to the Hope Lodge resident patients who receive extended treatment at Moffitt Cancer Center.
OncLive – April 24
Hatem Soliman, MD, a medical oncologist specializing in breast cancer at The Center for Women’s Oncology at Moffitt Cancer Center, says that calling this entire group of patients as having TNBC is an “oversimplification.”
Tampa Bay Times – April 24
The next Mole Patrol screening at Pier 60 is scheduled from 9 a.m. to 3 p.m. July 28, weather permitting. A half-dozen physicians as well as technicians and volunteers will be set up on the pier, under cover, to offer complimentary examinations, according to Dr. Jane Messina, medical director of Moffitt’s Mole Patrol. The Mole Patrol also will be at MacDill Air Force Base’s AirFest from 9 a.m. to 4 p.m. May 12.
European Pharmaceutical Review – April 24
A team of researchers at Moffitt Cancer Center has been working to learn more about how melanoma becomes resistant to BRAF inhibitors in order to develop new treatment strategies.
OncLive – April 23
In an interview with OncLive, Frederick L. Locke, MD, a medical oncologist at Moffitt Cancer Center, and an investigator on ZUMA-2 and the co-lead investigator on ZUMA-1, discussed the ongoing ZUMA-2 trial investigating axi-cel for patients with MCL.
SELF Magazine – April 23
The fact that she experienced severe pain suggests Miller has an aggressive form of the disease, Michael Jain, M.D., a hematologist with Moffitt Cancer Center, told SELF previously.
Gwinnett Daily Post – April 23
Each month, she racks up hundreds of miles traveled aboard a flight from Atlanta to Tampa, Fla., to visit a neuroendocrine specialist at Moffitt Cancer Center in addition to the visits at Emory Medical Center and Gwinnett Medical Center
The Oracle, April 22
Alexsa, a student at Ohio State and a former member of the dance team at the University of Alabama, is in her third of 12 chemotherapy treatments at Moffitt Cancer Center. She is enrolled in school remotely while she receives treatment in Tampa.
SELF Magazine – April 20
However, the particular form of non-Hodgkin's lymphoma that Miller appears to have is aggressive, meaning it grows quickly, Michael Jain, M.D., Ph.D., a hematologist with Moffitt Cancer Center, tells SELF. In cases of Burkitt lymphoma, it’s possible for someone to have sudden, excruciating pain, he says. Given that there are a lot of lymph nodes in the neck, Dr. Jain explains, it’s understandable that someone would have a lot of neck pain if a lymphoma was growing rapidly there.
Tampa Bay Times – April 20
Moffitt Cancer Center and its most generous supporters went surfin’ for a cure with a private Beach Boys concert at the 25th annual Magnolia Ball.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.